News - Page 6 of 13 - Xtant Medical

Xtant Medical Comments on Trading Activity of its Stock

February 26, 2021

BELGRADE, Mont. , Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it is not aware of any material, undisclosed corporate

Xtant Medical Announces Closing of $20 million Private placement

February 25, 2021

BELGRADE, Mont. , Feb. 25, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of its previously announced $20 million private

Xtant Medical Announces Fourth Quarter and Full Year 2020 Financial Results

February 24, 2021

BELGRADE, Mont. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended

Xtant Medical Announces $20 Million Private Placement

February 22, 2021

BELGRADE, Mont. , Feb. 22, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT) (the Company), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has entered into a definitive agreement with a single

Xtant Medical to Issue Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 24, 2021

February 17, 2021

BELGRADE, Mont. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full

Xtant Medical Announces Expiration of Rights Offering

December 7, 2020

BELGRADE, Mont. , Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the subscription period for its previously announced rights offering

Xtant Medical Announces Third Quarter 2020 Financial Results

October 29, 2020

BELGRADE, Mont. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30,

Xtant Medical Announces Record Date and Other Key Dates for Proposed $15 Million Rights Offering

October 22, 2020

BELGRADE, Mont. , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has set November 5, 2020 as the record date for its

Xtant Medical to Issue Third Quarter 2020 Financial Results on October 29, 2020

October 20, 2020

BELGRADE, Mont. , Oct. 20, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended

Xtant Medical Regains Compliance with NYSE American Continued Listing Standards

October 6, 2020

BELGRADE, Mont. , Oct. 06, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it received notification from the NYSE American LLC yesterday that

Xtant Medical Announces Closing of Debt Restructuring

October 1, 2020

BELGRADE, Mont. , Oct. 01, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has completed its previously announced debt restructuring

Xtant Medical Announces U.S. Commercial Launch of the Matriform® Si for Spinal Fusion Procedures

August 24, 2020

BELGRADE, Mont. , Aug. 24, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the U.S. commercial launch of the Matriform® Si, a silicated synthetic